AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
204.72
+4.25 (2.12%)
Apr 17, 2026, 11:45 AM EDT - Market open

AstraZeneca Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
311,847544,369403,142416,839422,228358,996
Market Cap Growth
38.51%35.03%-3.29%-1.28%17.61%35.39%
Enterprise Value
336,008564,816425,192434,122439,534381,505
Last Close Price
204.72175.50130.00134.45136.22115.85
PE Ratio
30.5053.6757.7870.58129.122896.25
PS Ratio
5.319.277.469.109.529.59
PB Ratio
6.4011.199.8810.6511.409.14
P/TBV Ratio
13.1311.279.9610.7311.488.42
P/FCF Ratio
26.5146.2740.5746.4048.4473.69
P/OCF Ratio
21.4037.3533.9940.2943.0560.20
EV/Sales Ratio
5.729.627.869.489.9110.20
EV/EBITDA Ratio
17.4329.0025.4731.9747.5850.29
EV/EBIT Ratio
23.5141.1042.5152.99116.99361.27
EV/FCF Ratio
28.5648.0142.7948.3250.4278.31
Debt / Equity Ratio
0.540.540.680.590.640.74
Debt / EBITDA Ratio
1.521.521.822.113.174.06
Debt / FCF Ratio
2.522.523.053.193.356.32
Net Debt / Equity Ratio
0.490.490.600.580.620.62
Net Debt / EBITDA Ratio
1.231.231.481.672.473.21
Net Debt / FCF Ratio
2.032.032.482.522.625.01
Asset Turnover
0.540.540.530.460.440.43
Inventory Turnover
1.801.801.911.631.811.91
Quick Ratio
0.680.680.670.590.640.71
Current Ratio
0.940.940.930.820.861.16
Return on Equity (ROE)
22.84%22.84%17.59%15.64%8.63%0.42%
Return on Assets (ROA)
10.40%10.40%7.90%7.16%4.90%-0.53%
Return on Invested Capital (ROIC)
14.27%14.27%10.90%9.84%6.55%-0.75%
Return on Capital Employed (ROCE)
17.22%17.22%13.63%11.64%4.91%1.63%
Earnings Yield
3.28%1.86%1.73%1.42%0.77%0.03%
FCF Yield
3.77%2.16%2.46%2.16%2.06%1.36%
Dividend Yield
1.56%0.91%1.15%1.08%1.03%1.17%
Payout Ratio
48.93%48.62%65.80%75.25%132.72%3442.86%
Buyback Yield / Dilution
0.06%0.06%-0.06%-0.13%-9.32%-8.68%
Total Shareholder Return
1.63%0.98%1.08%0.95%-8.29%-7.51%
Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q